XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition (Tables)
6 Months Ended
Jun. 30, 2021
Revenue from Contract with Customer [Abstract]  
Disaggregation of revenue
The following table represents Evolent’s revenue disaggregated by segment and end-market for the three and six months ended June 30, 2021 and 2020 (in thousands):
For the Three Months Ended June 30,For the Six Months Ended June 30,
20212020202120202021202020212020
Evolent Health ServicesClinical SolutionsEvolent Health ServicesClinical Solutions
Medicaid$52,064 $55,502 $53,648 $64,050 $112,993 $113,947 $96,987 $124,512 
Medicare6,346 14,061 90,761 64,206 14,684 29,246 176,544 126,560 
Commercial and other16,453 16,958 2,785 2,522 32,023 39,705 3,897 4,561 
Total$74,863 $86,521 $147,194 $130,778 $159,700 $182,898 $277,428 $255,633 
Contract with customer, asset and liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of June 30, 2021 and December 31, 2020 (in thousands):
June 30, 2021
December 31, 2020 (1)
Short-term receivables (2)
$240,060 $124,064 
Long-term receivables (2)
4,688 4,554 
Short-term contract assets— 329 
Short-term deferred revenue13,173 10,187 
Long-term deferred revenue4,932 3,593 
————————
(1)Amounts exclude $3.4 million of short-term receivables and $4.1 million of short-term deferred revenue reclassified to discontinued operations as of December 31, 2020.
(2)Excludes pharmacy claims receivable and premiums receivable

Changes in deferred revenue for the six months ended June 30, 2021 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$13,780 
Reclassification to revenue, as a result of performance obligations satisfied(8,726)
Cash received in advance of satisfaction of performance obligations13,051 
Balance as of end of period$18,105